Showing results (481-490 of 544) with videos related to
Sort By:
Pageof 55
Cancer Research|April 13, 2012
Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancerYan W Asmann, Brian M Necela, Krishna R Kalari, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
The tandem duplicator phenotype as a distinct genomic configuration in cancerFrancesca Menghi, Koichiro Inaki, XingYi Woo, et al.Pharmacogenetics and Genomics|June 19, 2019
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancerJames N Ingle, Krishna R Kalari, Yukihide Momozawa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.Arthritis Care & Research|December 13, 2021
Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning ApproachElena Myasoedova, Arjun P Athreya, Cynthia S Crowson, et al.JCI Insight|July 24, 2020
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole actionJunmei Cairns, James N Ingle, Tanda M Dudenkov, et al.Molecular Medicine (Cambridge, Mass.)|July 17, 2015
Antiinflammatory Activity of a Novel Folic Acid Targeted Conjugate of the mTOR Inhibitor EverolimusYingjuan Lu, Nikki Parker, Paul J Kleindl, et al.Nature Communications|January 6, 2016
A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choiceHaoxing Zhang, Hailong Liu, Yali Chen, et al.The Journal of Clinical Investigation|January 4, 2022
The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responsesSamantha A Chalmers, Rajalakshmy Ayilam Ramachandran, Sayra J Garcia, et al.BMJ Open|April 17, 2016
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancerSteven N Hart, Marissa S Ellingson, Kim Schahl, et al.Pageof 55